************* ************* PROGRESS NOTE  Assessment and Plan:      Exam Date: */**/****  Patient:******* * *********** (********)   Impression:  Glaucoma suspect based on optic nerve appearance  -- *** ** */**/**** - thinning **, */*/****: stable, */**/**** - changes likely due to caliper placement, */**/**** stable   -- CCT (*/**/****): RE 611 // LE 610 - thick  -- HVF */*/**** OD ******** ***** and Inferior Defects, OS poor fixation ******** arcuate defect and inferior defect, */**/**** - high FL OU, */**/**** - OD stable, OS new baseline  ---HVF today unreliable, no discernable progression but poor testing **, */**/****  Stable   -- IOP 18 OU no drops--->started Latanoprost */*/**** --> IOP 15-17 RE,16-18, LE. Taking now for 3 years without complication, IOP 16 OU today     Diabetes Mellitus type II, insulin dependent. With mild non-proliferative diabetic retinopathy   -- Discussed with patient the effects of chronic glucose elevation on his eyes and encouraged the patient on his A1c coming down and to work with his PCP on even better control of his glucose     Pseudophakia OU - posterior capsular opacification OS. Lenses well centered  -- S/p Phaco/IOL ** **/**/**** ****** 7.5 ********   -- S/p Phaco/IOL OD */**/**** ****** 12.5 ********      Epiretinal Membrane OU, OD>OS  --observe     Astigmatism  --Patient not wearing correction currently, reviewed with the patient that he could be seeing significantly better with correction. Patient prefers to return to clinic and see an optometrist at a separate time.     Dry eye, mild  Vision fluctuation, AM irritation and photophobia     Former high myope     COA pt since **/**      Plan:  Continue latanoprost qHS OU  HVF stable  If there is change in *** **,  give pt call, otherwise,   RTC 6m DFE , *** ** and HVF 24-2      Physician: ******* * ********, MD     */**/****       HPI: ******* * *********** (********), 73 y.o. year old male  from ******** : Patient presents with:  Follow-up visit    Still using Latanoprost OU Qhs. No changes to vision since last visit. No pain in either eye at present.     Last dose Latanoprost */**/**** ** PM   Primary Care Provider: **** ****, MD  Past ocular history:  Pseudophakia OU - posterior capsular opacification OS  -- S/p Phaco/IOL ** **/**/**** ****** 7.5 ********   -- S/p Phaco/IOL OD */**/**** ****** 12.5 ********   Glaucoma suspect based on optic nerve appearance  -- *** ** */**/****   Diabetes Mellitus  Epiretinal Membrane  Astigmatism  Former high myope  COA pt since **/**       Medications:   Current Outpatient Medications   Medication Sig   • buprenorphine HCl 2 mg sublingual tablet, sublingual Place under tongue once daily.   • DABIGATRAN ETEXILATE MESYLATE (PRADAXA ORAL) Take  by mouth.     • finasteride 2.5 mg oral tablet Take  by mouth.   • gabapentin 300 mg oral capsule Take 300 mg by mouth three times daily.   • INSULIN GLARGINE,***.REC.***** (LANTUS SUBQ) Inject 20 Units under the skin (****) once daily.   • latanoprost 0.005 % ophthalmic (eye) drops place 1 drop into both eyes at bedtime   • METFORMIN HCL (METFORMIN ORAL) Take  by mouth.     • OMEPRAZOLE ORAL Take  by mouth.     • torsemide 20 mg oral tablet Take 20 mg by mouth every eight hours.   • VALSARTAN (DIOVAN ORAL) Take 80 mg by mouth once daily.     No current facility-administered medications for this visit.         Medical history/PMH/Review of systems:   Patient Active Problem List   Diagnosis   • Diabetes mellitus, type 2 (HCC)   • Pseudophakia, both eyes   • PCO (posterior capsular opacification)   • Congestive heart failure (HCC)   • Acute diastolic heart failure (HCC)   • Primary open angle glaucoma of both eyes, indeterminate stage     Past Medical History:   Diagnosis Date   • A-fib (HCC)    • CAD (coronary artery disease)    • Congestive heart failure, unspecified **/*/****   • GERD (gastroesophageal reflux disease)    • HTN (hypertension)    • Migraine, unspecified, without mention of intractable migraine without mention of status migrainosus    • Morbid obesity (HCC)    • Neurologic disorder    • NIDDM (non-insulin dependent diabetes mellitus)    • OSA (obstructive sleep apnea)    • Pneumonia    • Unspecified cataract    • Unspecified hemorrhagic conditions         Allergies: has No Known Allergies.       has a past surgical history that includes DC cardioversion 2009; coronary angioplasty 2009; nissen fundoplication 1989; cataract removal (**/**/**); and cataract removal (*/**/**).   Reviewed systems for: fever, wt. loss, ENT, cardiovascular, pulmonary, GI, urinary, neurologic, endocrine, bleeding/blood disorders, AIDS/HIV, cancer/tumors, arthritis - all were negative except as noted above.         Family ocular history:   See scanned intake form or preadmission data in EPIC for full Family ocular and medical history.       Tobacco use:  reports that he quit smoking about 31 years ago. His smoking use included cigarettes. He has a 20.00 pack-year smoking history. He has never used smokeless tobacco.     EXAMINATION:   Base Exam     Visual Acuity (******* - Linear)       Right Left    Dist sc 20/25-1 20/30-1          Tonometry (Applanation, 2:30 PM)       Right Left    Pressure 15 16          Neuro/Psych     Oriented x3:  Yes               See EPIC ophthalmology module for exam information.      Assessment and Plan is now at the top of the note.   *, ******** ***, ***,  am functioning as a scribe for ******* ********, MD.      I have reviewed and verified the above scribed note of my visit with this patient as recorded by Sun ***.  I have reviewed and edited history and technician documentation, and performed all other elements to above examination documentation.  The attending physician is responsible for and agrees with the entire content of the note and has personally performed the HPI and the physical examination.      ******* ********, MD  ********* *********  ************* *************  ***** *** *********  **** ** **** ***, **** *****  ********, **  *****  (***) ***-****     Physician: ******* * ********, MD  